Direct economic impact of Parkinson's disease: a research survey in the United Kingdom.
The direct costs of care were evaluated prospectively in a sample of people with Parkinson's disease (PD) in the United Kingdom in 1998. The subjects were drawn from a random sample of general practitioner practices within a representative sample of 36 Regional Health Authorities and the equivalent. A total of 444 resource use questionnaires with usable data were returned (response rate, 59%). The total mean annual cost of care per patient for all patients by age was 5,993 pounds (9,554 euro, n = 432). Hoehn and Yahr stage significantly (P < 0.001) influenced expenditure by stage as follows: 0 and I, 2,971 pounds (4,736 euro, n = 110); II, pound 3,065 (4,886 euro, n = 89); III, 6,183 pounds (9,857 euro, n = 120); IV, 10,134 pounds (euro;16,155, n = 87); V, 18,358 pounds (29,265 euro, n = 17). National Health Service costs accounted for approximately 38% and social services for 34% of the direct costs of care. Drug expenditure accounted for 24% of overall costs in the <65 years age group and 10% in patients aged >85 years. A move from home to residential care was associated with an approximately 500% cost increase. In conclusion, PD imposes significant direct costs on public services and on individuals. These costs should be taken into account when allocating public funds.
Findley
Leslie
L
Oldchurch Hospital, Romford, United Kingdom.
Aujla
Manjit
M
Bain
Peter G
PG
Baker
Mary
M
Beech
Catherine
C
Bowman
Clive
C
Holmes
Jeremy
J
Kingdom
Wendy K
WK
MacMahon
Douglas G
DG
Peto
Viv
V
Playfer
Jeremy R
JR
D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000704:Analysis of Variance; D003625:Data Collection; D005260:Female; D017048:Health Care Costs; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D009313:National Health Programs; D010300:Parkinson Disease / Q000191:economics* / Q000453:epidemiology*; D011795:Surveys and Questionnaires; D006113:United Kingdom / Q000453:epidemiology